Pay in 4 interest-free payments of $6.36 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
A thorough examination of the feet including the evaluation of DPN, PAD, and foot deformities should be performed annually in all people with diabetes, and the interval should be shortened based on the level of risk
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin in patients with type 2 diabetes and inadequate glycemic control: a randomized, double-blind, placebo-controlled study
G protein-biased agonists represent one promising direction
From dose titration, side effect management, insurance coverage changes, and unlimited provider messagingwe got you
When levels drop below optimal ranges, the body signals distress through fatigue, weakness, and neurological complications
US$ 24.23
US$ 20.76
US$ 26.97
US$ 25.07
US$ 29.23
